Sheeyla / Shutterstock.com
25 June 2024NewsBig PharmaLiz Hockley
High Court says disclosure ‘last resort’ for patent cases in stoma bag dispute
UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Biotechnology
25 April 2024 UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims in Netherlands division of UPC on same day.
Europe
20 February 2024 It remains to be seen whether AI developers in the medical sector will benefit from the UK’s ‘flexible’ regulatory environment or find the lack of cohesion detrimental, say Jackie Mulryne and Beatriz San Martin of Arnold & Porter.
Editor's picks
Editor's picks
Biotechnology
25 April 2024 UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims in Netherlands division of UPC on same day.
Europe
20 February 2024 It remains to be seen whether AI developers in the medical sector will benefit from the UK’s ‘flexible’ regulatory environment or find the lack of cohesion detrimental, say Jackie Mulryne and Beatriz San Martin of Arnold & Porter.
Biotechnology
25 April 2024 UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims in Netherlands division of UPC on same day.
Europe
20 February 2024 It remains to be seen whether AI developers in the medical sector will benefit from the UK’s ‘flexible’ regulatory environment or find the lack of cohesion detrimental, say Jackie Mulryne and Beatriz San Martin of Arnold & Porter.